Investor Type | Firm |
Industries | BioTech • Entertainment (& Sports) • Blockchain (& Cryptos) • Food & Beverage • Material Science • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness) • Pharmaceutical (& Medicine) • Woman Focused |
Stages | Early, Seed, Series A, Latin America, Series B |
Investing | United States • Brazil |
Investment Range | $100,000 - $3,000,000 |
Investment Sweet Spot | $1,600,000 |
Assets Under Management | $26,000,000 |
Babel Ventures is an early stage consumer biotech venture capital based in San Francisco and was founded in 2017.